Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration Miniperspective

被引:40
作者
Siu, Michael [1 ]
Ghosh, Arundhati Sengupta [1 ]
Lewcock, Joseph W. [2 ]
机构
[1] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA
[2] Denali Therapeut, 151 Oyster Point Blvd, San Francisco, CA 94080 USA
关键词
MIXED-LINEAGE KINASE-3; GANGLION-CELL DEATH; AXONAL INJURY; BEARING KINASE; NEURONAL DEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; IN-VIVO; DLK;
D O I
10.1021/acs.jmedchem.8b00370
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dual leucine zipper kinase (DLK, MAP3K12) is an essential driver of the neuronal stress response that regulates neurodegeneration in models of acute neuronal injury and chronic neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. In this review, we provide an overview of DLK signaling mechanisms and describe selected small molecules that have been utilized to inhibit DLK kinase activity in vivo. These compounds represent valuable tools for understanding the role of DLK signaling and evaluating the potential for DLK inhibition as a therapeutic strategy to prevent neuronal degeneration.
引用
收藏
页码:8078 / 8087
页数:10
相关论文
共 76 条
  • [11] Estrada A., 2014, Preparation of pyrazolylpyridinamine derivatives for use as DLK inhibitors, Patent No. 2014111496
  • [12] Estrada A., 2016, PCT Int. Appl. WO, Patent No. 2016142310
  • [13] Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
    Estrada, Anthony A.
    Sweeney, Zachary K.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) : 6733 - 6746
  • [14] JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death
    Fernandes, Kimberly A.
    Harder, Jeffrey M.
    Fornarola, Laura B.
    Freeman, Robert S.
    Clark, Abbot F.
    Pang, Iok-Hou
    John, Simon W. M.
    Libby, Richard T.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (02) : 393 - 401
  • [15] Ferraris D, 2013, FUTURE MED CHEM, V5, P1923, DOI [10.4155/FMC.13.150, 10.4155/fmc.13.150]
  • [16] Fu J, 2016, PCT Int. Appl. WO, Patent No. 2016100380
  • [17] DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity
    Ghosh, Arundhati Sengupta
    Wang, Bei
    Pozniak, Christine D.
    Chen, Mark
    Watts, Ryan J.
    Lewcock, Joseph W.
    [J]. JOURNAL OF CELL BIOLOGY, 2011, 194 (05) : 751 - 764
  • [18] Axon Regeneration Requires a Conserved MAP Kinase Pathway
    Hammarlund, Marc
    Nix, Paola
    Hauth, Linda
    Jorgensen, Erik M.
    Bastiani, Michael
    [J]. SCIENCE, 2009, 323 (5915) : 802 - 806
  • [19] Han B, 2015, CN Pat. Appl., Patent No. [CN104387391, 104387391]
  • [20] Han B, 2015, CN Pat. Appl., Patent No. [CN104370880, 104370880]